| BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | ||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | ||||||||||||||||||||||||||
| Operating Cash Flow | (10,921$) | (11,121$) | (27,893$) | (15,215$) | (14,835$) | (15,442$) | (13,392$) | (17,581$) | (7,086$) | (7,917$) | (8,645$) | (23,054$) | (9,043$) | (8,677$) | (27,706$) | (32,346$) | (11,148$) | (8,642$) | (20,772$) | (39,634$) | (10,260$) | (1,794$) | (4,894$) | (7,435$) | (5,040$) | (21,475$) | (25,369$) | (11,710$) | |||||||||||||||||||||
| Investing Cash Flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 10,923$ | 11,000$ | 14,999$ | 28,152$ | 14,062$ | 16,410$ | 13,419$ | 17,583$ | 7,038$ | 7,949$ | 8,613$ | 23,006$ | (7,157$) | 8,677$ | 23,176$ | 24,316$ | 11,148$ | 8,642$ | 13,772$ | 33,604$ | 16,223$ | 7,756$ | 10,744$ | 13,163$ | |||||||||||||||||||||||||
| End Cash Position | 786$ | 784$ | 905$ | 13,799$ | 862$ | 1,635$ | 667$ | 640$ | 638$ | 686$ | 654$ | 686$ | 734$ | 11,105$ | 27,305$ | 27,305$ | 31,835$ | 39,865$ | 39,865$ | 39,865$ | 46,865$ | 52,895$ | 46,932$ | 40,970$ | 35,120$ | 29,392$ | 23,888$ | 23,881$ | 18,825$ | 14,325$ | 14,325$ | ||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (10,921$) | (11,121$) | (27,893$) | (15,215$) | (14,835$) | (15,442$) | (13,392$) | (17,581$) | (7,086$) | (7,917$) | (8,645$) | (23,054$) | (9,043$) | (8,677$) | (27,706$) | (32,346$) | (11,148$) | (8,642$) | (20,772$) | (39,634$) | (10,260$) | (1,794$) | (4,894$) | (7,435$) | (5,040$) | (21,475$) | (25,369$) | (11,710$) | |||||||||||||||||||||